Article info
PDFPostScript
Letter
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases
- Correspondence to Dr Hung Shih-Chang, Nantou Hospital, Nantou, Taiwan; shihchan{at}gmail.com
Citation
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases
Publication history
- First published September 14, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (19 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.